Targeting hyaluronic acid family for cancer chemoprevention and therapy.
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushThe immunological effect of hyaluronan in tumor angiogenesisBreaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer TherapyHYAL-2-WWOX-SMAD4 Signaling in Cell Death and Anticancer ResponseCD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating CellsAntitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).Ameliorative Effect of Curcumin-Encapsulated Hyaluronic Acid-PLA Nanoparticles on Thioacetamide-Induced Murine Hepatic FibrosisStabilized nanosystem of nanocarriers with an immobilized biological factor for anti-tumor therapy.The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activityHyaluronan as a therapeutic target in human diseasesLoss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid SynthesispH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin.The role of hyaluronan in the pathobiology and treatment of respiratory disease.The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma.The Role of CD44 in Disease Pathophysiology and Targeted Treatment.Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.Carcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment.Involvement of glycogen debranching enzyme in bladder cancer.Multicomponent High-throughput Drug Screening via Inkjet Printing to Verify the Effect of Immunosuppressive Drugs on Immune T Lymphocytes.Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.Inhibition of Systemic Hyaluronan Synthesis Exacerbates Murine Hepatic Carcinogenesis.Biomacromolecule/lipid hybrid nanoparticles for controlled delivery of sorafenib in targeting hepatocellular carcinoma therapy.Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth.Cancer Cell Glycocalyx and Its Significance in Cancer ProgressionCD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
P2860
Q26741215-CF1722E6-73D1-43E4-BB47-5DDBA80931FDQ26771483-59701EA9-0ADA-4D78-9C74-F3F0738C048CQ26784055-719CC375-F1C8-47E5-826F-6A8BEC5B45A9Q28079276-6B16E0A9-D3B3-42EB-A6EE-C1B0A92DFAE8Q28084610-287A6597-9F75-412F-898B-27813112C4C0Q33648449-41BDA3B5-BD13-4758-B68F-09BD54FCB79FQ33688875-C300F2C0-8EA0-46C0-8F5B-8E081B8E1F14Q36009814-0894E936-1AAF-4973-A531-1F3B92979FF6Q36123305-D549F418-3A38-4BCE-B6AA-73DD654BA83BQ36234375-42DD91DA-F25B-43C5-BC2C-8808BC0A36C5Q36271788-5A36936B-DE70-4CFB-8C86-C15F2F7797C7Q36404904-572B2162-6215-45AE-AE0B-1DF559467E68Q36578627-F0A6D061-63B3-4AB9-9CC7-A1529DE9DA1DQ36642643-B94A70D9-1E2B-4BCB-AC50-647BA6C5D582Q36846825-FD0D6148-5064-4710-B7DB-D65E9BF2022BQ36902371-910ED0A4-033D-44B3-892B-CEDCC50D8A11Q37729238-66D6C51D-4C0B-47BC-9495-EADB03B778B7Q38466771-B9CFD01D-1452-48B6-A781-09FE0B6B13B9Q38717148-2A8ED5BE-AE9D-4F48-84A5-5551EEF76922Q38778198-6E08C3AF-C5A0-4189-86DA-6E0C309A3412Q38838567-4F50EA02-2981-43C3-833C-E6DB02C7EC33Q39353346-B29CF73B-E4E9-4CE0-AA2D-2919F946E394Q41109573-C8DCA515-241E-43FC-89D4-5FBF4D64DC8DQ47853449-A5220278-5E9A-4752-A6B3-8DFE07C2170CQ53177828-631EE9C5-4BA0-4D12-94CB-4BEE9321D157Q53639202-CD566389-EC30-4F3C-9A3F-117330561C6AQ54967662-4D3E7A0E-D7C3-419C-945C-CAC4F6562FE0Q57168005-21C0E14B-9FD2-411A-BA1F-1EB9F9762DD5Q58697956-DD87A827-B5FE-4E1E-B270-420585008FBE
P2860
Targeting hyaluronic acid family for cancer chemoprevention and therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Targeting hyaluronic acid family for cancer chemoprevention and therapy.
@en
type
label
Targeting hyaluronic acid family for cancer chemoprevention and therapy.
@en
prefLabel
Targeting hyaluronic acid family for cancer chemoprevention and therapy.
@en
P2860
P1476
Targeting hyaluronic acid family for cancer chemoprevention and therapy.
@en
P2093
Summan Mirza
Vinata B Lokeshwar
P2860
P356
10.1016/B978-0-12-800092-2.00002-2
P577
2014-01-01T00:00:00Z